Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2016 for the Clinical Practice of Hereditary Colorectal Cancer (Translated Version)
Hideyuki Ishida(Tokyo Medical and Dental University), Osamu Tsuruta(Kurume University), Narikazu Boku(Tokyo Medical University), Yoshie Murakami(Toho University), Takako Eguchi Nakajima(St. Marianna University School of Medicine), Takeshi Nakajima(Osaka International Cancer Institute), Akihiko Tsuji(Kagawa University), Yasuhiro Inoue(Mie University), Takao Hinoi(Hiroshima University), Yukihide Kanemitsu(National Cancer Center), Nobuo Koinuma(Aomori Prefectural Central Hospital), Keiichi Takahashi(Tokyo Metropolitan Komagome Hospital), Naohiro Tomita(Toyonaka Municipal Hospital), Kiwamu Akagi(Kuwait University), Shiro Oka(Hiroshima University), Kohji Tanakaya(Iwakuni Medical Center), Kentaro Yamazaki(Shizuoka Cancer Center), Takayuki Morita(Aomori Prefectural Central Hospital), Tatsuro Yamaguchi(Tokyo Metropolitan Komagome Hospital), Michio Itabashi(Tokyo Women's Medical University), Yusuke Kinugasa(The Japanese Society of Gastroenterological Surgery), Yutaka Saito(National Cancer Center), Yoichi Ajioka(Niigata University), Yasuyuki Miyakura(Jichi Medical University), Hideki Ueno(National Defense Medical College), Kensuke Kumamoto(Kagawa University), Yoshiharu Sakai(The Japanese Society of Gastroenterological Surgery), Takayuki Yoshino(University of Tsukuba), Hideki Shimodaira(Tohoku Medical and Pharmaceutical University), Akiko Chino(Japanese Foundation For Cancer Research), Kei Muro(Aichi Cancer Center), Akira Hirasawa(Okayama University), Hirotoshi Hasegawa(Tokyo Dental College Ichikawa General Hospital), Megumi Ishiguro(Tokyo Medical and Dental University), Shinji Tanaka(Onomichi General Hospital), Yojiro Hashiguchi(Teikyo University), Yoshinori Ito(National Cancer Center Hospital East), Hiroshi Kawano(St. Mary’s Hospital), Toshiaki Tanaka(Sapporo Medical University), Yasuhiro Shimada(Tokyo Metropolitan Komagome Hospital), Masahiro Yoshida(Jikei University School of Medicine), Keisuke Uehara(National Defense Medical College), Keiko Murofushi(St. Marianna University School of Medicine), Norihiro Kokudo(The Cancer Institute Hospital), Takahiro Fujimori(Hyogo Social Welfare Corporation), Yuh Sakata(Misawa City Hospital), Genichi Nishimura(Misawa City Hospital), Shigeki Sekine(Keio University), Tetsuya Hamaguchi(National Cancer Center Hospital East), Soichiro Ishihara(University of Tokyo Hospital)
Cited by 47
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer
|Nature Medicine|2019|1.5k
Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer
|New England Journal of Medicine|2019|1.5k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k